The Day After Trump Called Intel’s Chief ‘Conflicted,’ Former Directors Call for a New Company, a New Board and a New CEO

2 months 1 week ago
The group of former Intel board members— Charlene Barshefsky, Reed Hundt, James Plummer, and David Yoffie—pointed out that the company is on its fourth CEO in seven years with little improvement in results. They argued that only a dramatic break could restore Intel’s competitiveness and protect U.S. national security interests, with a rescue plan focused specifically on emancipating Intel’s “Foundry” business, the manufacturing assets from which Intel produces semiconductor chips for its own products and for third-party customers.
David Yoffie

Former Intel Board Members: America’s Champion Is Likely to Retreat, and We Still Need a Leading-Edge Chip Manufacturer

2 months 1 week ago
A little over five years ago, the Trump administration announced Operation Warp Speed to deliver a vaccine for COVID-19. It was one of the most stunning successes of Trump’s first term. Recognizing a crisis, the U.S. government facilitated a public-private partnership that likely saved millions of lives in record time. Now we must do it again. As a country, we have a strategic imperative to win in artificial intelligence and secure our supply chains for critical technologies, including communications, computing, and advanced military systems. Time is of the essence. Yet the Administration’s plans for AI and self-sufficiency are in serious jeopardy unless we have American-owned, leading-edge chip manufacturing plants on American soil.
David Yoffie

After a Lag, Consumers Begin to Feel the Pinch of Tariffs

2 months 1 week ago
And while inflation was fairly modest, prices were still going up, just at a gentle rate that most consumers would be hard-pressed to detect. Since early March, prices for imported goods have risen about 3 percent on average — with larger increases on goods from China, according to Alberto Cavallo, a Harvard economist.
Alberto Cavallo

A Good Plan to Keep Social Security Solvent

2 months 1 week ago
Andrew Biggs’s “A Risky Plan for Social Security” warns that the bipartisan reform plan to provide long-term solvency for the Social Security system proposed by Sens. Bill Cassidy (R., La.) and Tim Kaine (D., Va.) is too risky (op-ed, July 25). But the Cassidy-Kaine plan is much less risky than ignoring Social Security’s current $25 trillion funding gap and allowing its trust fund to be depleted by 2033.
Robert Kaplan

Research Identifies New Ways To Supercharge Cancer Immunotherapy

2 months 2 weeks ago
Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs in the balance due to the government’s decision to terminate large numbers of federally funded grants and contracts across Harvard University. In a discovery that could expand the array of current cancer immunotherapy treatments, scientists at Harvard Medical School have identified a new molecular brake that hinders the ability of T cells to attack tumors. The research, published Aug. 12 in Nature…
By EKATERINA PESHEVA

Could Lithium Explain — and Treat — Alzheimer’s Disease?

2 months 3 weeks ago
Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs in the balance due to the government’s decision to terminate large numbers of federally funded grants and contracts across Harvard University. What is the earliest spark that ignites the memory-robbing march of Alzheimer’s disease? Why do some people with Alzheimer’s-like changes in the brain never go on to develop dementia? These questions have bedeviled neuroscientists for decades. Now, a team of…
By STEPHANIE DUTCHEN